EricScript v0.5.5 (Tamura et al. 2026)
EricScript v0.5.5: Default parameters; alignment method Multiple; aligner BWA v0.7.17, BLAT v37x1; GRCh38; filtered output used where available.
Overview
An explanatory profile has not yet been reviewed for this record.
Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.
Model Capabilities & Hardware Requirements
Deployment facts recorded for EricScript v0.5.5 (Tamura et al. 2026). Fields the record does not carry are marked not recorded.
Evaluated Checkpoint: v0.5.5
Evaluations and results
4 evaluations · 24 results. Different protocols are not a single leaderboard.
Sorted by F1 (all fusions, conventional RNA-seq of cell lines) (higher is better). The best value in each column is highlighted. Decimals are rounded for display; each value links to the printed value and its source.
| Tested configuration | Protocol and dataset | F1 (all fusions, conventional RNA-seq of cell lines) | F1 (all fusions, targeted RNA-seq of cell lines) | F1 (driver fusions, conventional RNA-seq of cell lines) | F1 (driver fusions, targeted RNA-seq of cell lines) | False negatives (all fusions, conventional RNA-seq of cell lines) | False negatives (all fusions, targeted RNA-seq of cell lines) | False negatives (driver fusions, conventional RNA-seq of cell lines) | False negatives (driver fusions, targeted RNA-seq of cell lines) | False positives (all fusions, conventional RNA-seq of cell lines) | False positives (all fusions, targeted RNA-seq of cell lines) | False positives (driver fusions, conventional RNA-seq of cell lines) | False positives (driver fusions, targeted RNA-seq of cell lines) | Precision (all fusions, conventional RNA-seq of cell lines) | Precision (all fusions, targeted RNA-seq of cell lines) | Precision (driver fusions, conventional RNA-seq of cell lines) | Precision (driver fusions, targeted RNA-seq of cell lines) | Recall (all fusions, conventional RNA-seq of cell lines) | Recall (all fusions, targeted RNA-seq of cell lines) | Recall (driver fusions, conventional RNA-seq of cell lines) | Recall (driver fusions, targeted RNA-seq of cell lines) | True positives (all fusions, conventional RNA-seq of cell lines) | True positives (all fusions, targeted RNA-seq of cell lines) | True positives (driver fusions, conventional RNA-seq of cell lines) | True positives (driver fusions, targeted RNA-seq of cell lines) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EricScript v0.5.5 (Tamura et al. 2026)Evaluation | All fusions, conventional RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3), CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines) | 0.01 | Not reported | Not reported | Not reported | 665 | Not reported | Not reported | Not reported | 160,271 | Not reported | Not reported | Not reported | 0 | Not reported | Not reported | Not reported | 0.54 | Not reported | Not reported | Not reported | 785 | Not reported | Not reported | Not reported |
| EricScript v0.5.5 (Tamura et al. 2026)Evaluation | All fusions, targeted RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3), Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines) | Not reported | 0.23 | Not reported | Not reported | Not reported | 123 | Not reported | Not reported | Not reported | 422 | Not reported | Not reported | Not reported | 0.16 | Not reported | Not reported | Not reported | 0.39 | Not reported | Not reported | Not reported | 80 | Not reported | Not reported |
| EricScript v0.5.5 (Tamura et al. 2026)Evaluation | Driver fusions, conventional RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5), CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines) | Not reported | Not reported | 0.89 | Not reported | Not reported | Not reported | 12 | Not reported | Not reported | Not reported | 0 | Not reported | Not reported | Not reported | 1 | Not reported | Not reported | Not reported | 0.8 | Not reported | Not reported | Not reported | 49 | Not reported |
| EricScript v0.5.5 (Tamura et al. 2026)Evaluation | Driver fusions, targeted RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5), Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines) | Not reported | Not reported | Not reported | 0.91 | Not reported | Not reported | Not reported | 4 | Not reported | Not reported | Not reported | 0 | Not reported | Not reported | Not reported | 1 | Not reported | Not reported | Not reported | 0.83 | Not reported | Not reported | Not reported | 20 |
All 24 result rows with coverage, uncertainty and sources
Filter evaluations
Applied filters: All linked evaluations
Source checking is not independent reproduction. Release 2026-11-21-adc15377fab2.
Use this configuration
How it works, versions and access
Additional methodological details, versions and access terms have not yet been extracted into a structured profile for this configuration. Consult the linked sources and evaluation records below.
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
3 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
Facets: method types1 values
| Discovering chimeric transcripts in paired-end RNA-seq data by using EricScript Benelli et al. 2012 section 2.6: "we trained an AdaBoost classifier"; section 2.6.4: the classifier, trained with synthetic data, gives the EricScore that ranks candidate fusions Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: Bioinformatics 28(24):3232-3239, published 2012-12-01 (version of record, publisher HTML full text) | conflicting claim ["source-hash-verification","automated-source-review"] · 2026-10-12 Audit detailsCorrect the method type from conventional_pipeline to supervised_machine_learning (use-case baseline review 2026-10-12, table 1). Issue #121's locator (Tamura 2026 supplement) is wrong: it does not mention AdaBoost. Evidence from docs/reviews/use-cases/baselines-2026-10-12.md. Independent review 2026-10-12: approved. Section 2.6: "we trained an AdaBoost classifier" on the GJS, ES and US scores; Section 2.6.4: trained with synthetic data, it gives the EricScore. EricScript remains an alignment-based caller whose candidates are ranked by this learned score. See docs/reviews/2026-10-12-method-type-corrections.md. Conflicting source claim: Field: Claim: metadata-correction-tags-20261012-252da1e1ea4c4be9003b Source artifact SHA-256: Hash scope: OUP refuses scripted downloads (HTTP 403 for the PDF and the HTML, from curl and from an in-page fetch). The hash is the SHA-256 of the UTF-8 innerText (44,359 bytes) of the element .article-body in the article page as rendered in Chrome on 2026-10-12. It describes one retrieval and depends on the browser's text rendering; it is not a hash of publisher bytes. Bibliographic data checked against Crossref (10.1093/bioinformatics/bts617) and Europe PMC (PMID 23093608, not in PMC). Extraction artifact SHA-256: |
Facets: method types1 values
| Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies Benelli et al. 2012 section 2.6: "we trained an AdaBoost classifier"; section 2.6.4: the classifier, trained with synthetic data, gives the EricScore that ranks candidate fusions Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: NPJ Precision Oncology 10:199, published 2026-04-04; PMC13230599 full-text XML | conflicting claim ["source-hash-verification","automated-source-review"] · 2026-10-12 Audit detailsCorrect the method type from conventional_pipeline to supervised_machine_learning (use-case baseline review 2026-10-12, table 1). Issue #121's locator (Tamura 2026 supplement) is wrong: it does not mention AdaBoost. Evidence from docs/reviews/use-cases/baselines-2026-10-12.md. Independent review 2026-10-12: approved. Section 2.6: "we trained an AdaBoost classifier" on the GJS, ES and US scores; Section 2.6.4: trained with synthetic data, it gives the EricScore. EricScript remains an alignment-based caller whose candidates are ranked by this learned score. See docs/reviews/2026-10-12-method-type-corrections.md. Conflicting source claim: Field: Claim: metadata-correction-tags-20261012-252da1e1ea4c4be9003b Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record Extraction artifact SHA-256: |
Facets: method types1 values
| Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) Benelli et al. 2012 section 2.6: "we trained an AdaBoost classifier"; section 2.6.4: the classifier, trained with synthetic data, gives the EricScore that ranks candidate fusions Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 41698_2026_1397_MOESM1_ESM.pdf as served by the publisher | conflicting claim ["source-hash-verification","automated-source-review"] · 2026-10-12 Audit detailsCorrect the method type from conventional_pipeline to supervised_machine_learning (use-case baseline review 2026-10-12, table 1). Issue #121's locator (Tamura 2026 supplement) is wrong: it does not mention AdaBoost. Evidence from docs/reviews/use-cases/baselines-2026-10-12.md. Independent review 2026-10-12: approved. Section 2.6: "we trained an AdaBoost classifier" on the GJS, ES and US scores; Section 2.6.4: trained with synthetic data, it gives the EricScore. EricScript remains an alignment-based caller whose candidates are ranked by this learned score. See docs/reviews/2026-10-12-method-type-corrections.md. Conflicting source claim: Field: Claim: metadata-correction-tags-20261012-252da1e1ea4c4be9003b Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record Extraction artifact SHA-256: |
Sources and history
Release 2026-11-21-adc15377fab2 · Record review: source checked
2 source records and release history
- Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies · Original source · NPJ Precision Oncology 10:199, published 2026-04-04; PMC13230599 full-text XML
- Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Original source · 41698_2026_1397_MOESM1_ESM.pdf as served by the publisher
Technical metadata and record identifiers
Technical metadata for this record is tracked under stable ID rna-fusion-20261009-config-tamura2026-ericscript.
Source locator: Supplementary Table 1; Methods 'Detection of gene fusions by each algorithm'
Related records
- configuration of: EricScript
- subject: EricScript v0.5.5 (Tamura et al. 2026): facets.method_types
- system: EricScript on all fusions, conventional RNA-seq (Tamura et al. 2026)
- system: EricScript on all fusions, targeted RNA-seq (Tamura et al. 2026)
- system: EricScript on driver fusions, conventional RNA-seq (Tamura et al. 2026)
- system: EricScript on driver fusions, targeted RNA-seq (Tamura et al. 2026)
How to cite
EricScript v0.5.5 (Tamura et al. 2026). Rewire biological model benchmark database, release 2026-11-21-adc15377fab2. https://benchmarks.rewirebio.io/database/configuration/rna-fusion-20261009-config-tamura2026-ericscript/
Release 2026-11-21-adc15377fab2. Rankings and values change between releases, so keep the release id in the citation. Cite the original publication as well for any value you reuse: each result links its source.
The compilation and annotations made by Rewire in this release are offered under CC BY 4.0; values and text taken from cited sources stay under the terms of those sources and are not covered by this licence. Data licence